Status:
RECRUITING
Levels of Visfatin/NAMPT in Human Milk
Lead Sponsor:
Paolo Manzoni Study Group
Collaborating Sponsors:
Università degli Studi del Piemonte Orientale Amedeo Avogadro
Conditions:
Visfatin Levels in Maternal Milk Samples
Birth Weight
Eligibility:
All Genders
Brief Summary
Visfatin, released in maternal milk at different concentrations related to the maternal conditions, could act as a biomarker with a prognostic/predictive value to determine different newborn clinical ...
Detailed Description
The aim of the study is to analyse a retrospective cohort of well characterized mothers in their post-partum period, and to measure Visfatin levels through collection of maternal milk samples. They wi...
Eligibility Criteria
Inclusion
- Healthy male and female infants born after 37 weeks' gestation who do not have conditions related to congenital abnormalities
- Maternal hospitalization
- Acquisition of the informed consent form signed by the patient
Exclusion
- Refusal of the patient to participate in the study
- Presence of hypogalactia or agalactia in the patient
Key Trial Info
Start Date :
October 24 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 23 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06487286
Start Date
October 24 2024
End Date
April 23 2025
Last Update
November 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale degli Infermi - ASL BI
Ponderano, BI, Italy, 13875